Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery

By J. Cosnes, I. Nion‐Larmurier, L. Beaugerie, P. Afchain, E. Tiret, J. Gendre. Gut, 2005

691 citations recorded by the source corpus.

Subfields: Epidemiology, Gastroenterology, Genetics

View Paper: https://www.semanticscholar.org/paper/c1b35ca27047d79b2101ac3d306b8a8e63dd07c0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Stefan Schreiber

In Genetics

1. Stefan Schreiber

Citations in the corpus

• Guidelines for the management of inflammatory bowel disease in adults (2011, background): “In addition, despite clear changes in the effective medical management of Crohn's disease, evidence to date would suggest that there has been little change in the natural history of the disease and hence the need for surgery.”
• Certolizumab pegol for the treatment of Crohn’s disease (2011, background): “Optimizing outcomes in CD requires rapid control of inflammation [Cosnes et al. 2005].”